Barrett’s Esophagus Market Analysis and Size

Barrett's esophagus is estimated to affect over 12 million adults in the Americas, with over 1.5 million having only been diagnosed. Furthermore, it is expected that approximately 0.5 percent of Barrett's esophagus patients would acquire esophageal cancer.

Barrett's esophagus affects more than 10% of people with GERD. Barrett's esophagus has intestinal cells that are more resistant to stomach acid than squamous cells, implying that the tissue alterations occur to protect the esophagus from acid exposure. This disease is more prevalent in men than in women, and it is more common in white people than in Hispanic people. It is uncommon in Asian and black people.

Data Bridge Market Research analyses that the Barrett’s esophagus market was valued at USD 4.43 billion in 2021 and is expected to reach USD 6.50 billion by 2029, registering a CAGR of 4.90% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get PDF Sample with Detail Analysis: - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-barretts-esophagus-market

Barrett’s Esophagus Market Dynamics

Drivers

·       Changing lifestyle of people

The continuously changing lifestyle of people is estimated to enhance the Barrett’s esophagus market's growth. Growing obesity rates and increased alcohol consumption, both of which cause GERD in people and lead to Barrett's esophagus, are estimated to propel the market forward. Along with this, growing addiction of smoking is the risk factor resulting in Barrett’s esophagus and hence, influencing the market dynamics during the forecast period of 2022-2029.

·       Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of Barrett’s esophagus market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

·       Growing number of geriatric population

The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to get Barrett’s esophagus, further estimated to enhance the market’s growth rate.

·       Surging incidences of chronic heartburn and acid reflux

The increasing incidences of chronic heartburn and acid refluxis anticipated to influence the growth of Barrett’s esophagus market. Barrett's esophagus is more likely to develop if you have GERD that doesn't improve when you use proton pump inhibitors or if you have GERD that requires daily medication.

Furthermore, rising initiatives by public and private organizations to spread awareness and family history with thyroid diseases will expand the Barrett’s esophagus market. Additionally, rising level of disposable income and increasing number of patients suffering from GERD will result in the expansion of Barrett’s esophagus market.

Opportunities

·       Increase in the number of research and development activities      

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Barrett’s esophagus market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Patient Epidemiology Analysis

Barrett’s esophagus market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Get TOC in Detail of this report: - https://www.databridgemarketresearch.com/toc/?dbmr=global-barretts-esophagus-market

Global Barrett’s Esophagus Market Scope

The Barrett’s esophagus market is segmented on the basis of type, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

·       No Dysplasia

·       Low-Grade Dysplasia

·       High Grade Dysplasia

·       Others

Treatment

·       Medication

·       Antacids, proton pump inhibitors

·       H2 blockers

·       Promotility agents

·       Others

·       Surgery

·       Cryotherapy

·       Radiofrequency ablation

·       Endoscopic resection

·       Others

Diagnosis

·       Endoscopy

·       Biopsy

·       Others

Route of Administration

·       Oral

·       Rectal

·       Parenteral

·       Others

End-Users

·       Hospitals

·       Specialty Clinics

·       Homecare

·       Others

Distribution Channel

·       Hospital Pharmacy

·       Retail Pharmacy

·       Online Pharmacy

·       Others

Barrett’s Esophagus Market Regional Analysis/Insights

The Barrett’s esophagus market is analysed and market size insights and trends are provided by country, type, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Barrett’s esophagus market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the Barrett’s esophagus market because of the growing prevalence of gastric imbalance diseases as well as obesity and rising healthcare expenditure in this region. Additionally, the presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to rising prevalence of obesity and surging number of generic manufacturers in this region. Also, development of healthcare infrastructure and high alcohol consumption in populated countries will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Browse in-depth Full Research Report: - https://www.databridgemarketresearch.com/reports/global-barretts-esophagus-market

Some of the major players operating in the Barrett’s esophagus market are:

·       GlaxoSmithKline plc (UK)

·       Novartis AG (Switzerland)

·       Bayer AG (Germany)

·       Eli Lilly and Company (US)

·       Merck & Co., Inc. (US)

·       AstraZeneca (UK)

·       Johnson & Johnson Private Limited (US)

·       Cipla Inc. (US)

·       Abbott (US)

·       AbbVie Inc. (US)

·       Merck KGaA (Germany)

·       Sun Pharmaceutical Industries Ltd. (India)

·       Aurobindo Pharma (India)

·       Lupin (India)

·       Dr. Reddy’s Laboratories Ltd. (India)

·       Pfizer Inc. (US)

·       Sanofi (France)

·       F. Hoffmann-La Roche Ltd. (Switzerland)

·       Boehringer Ingelheim International GmbH. (Germany)

·       Procter & Gamble (US)

·       Takeda Pharmaceutical Company Limited (Japan)

·       Eisai Co., Ltd. (Japan)

Related Reports: -

Healthcare Biometrics Market – Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-healthcare-biometrics-market

Brain Monitoring Devices Market – Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-brain-monitoring-devices-market

Single Tooth Implants and Dental Bridges Market Growth, Demand, Size, & Forecast To 2029 https://www.databridgemarketresearch.com/reports/global-single-tooth-implants-and-dental-bridges-market

Depth Filtration Market –Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-depth-filtration-market

Medical Gloves Market Size, Share, Research, & Forecast To 2029 https://www.databridgemarketresearch.com/reports/global-medical-gloves-market

Hydronephrosis Market – Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-hydronephrosis-market

Anesthesia Devices Market – Industry Trends and Forecast to 2029 | Data Bridge Market Research https://www.databridgemarketresearch.com/reports/global-anesthesia-devices-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com